# Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors

> **NCT02747407** · — · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 55 (actual)

## Conditions studied

- Astrocytoma
- Glioma
- Oligodendroglioma

## Interventions

- **BIOLOGICAL:** Hepatitis A Vaccine
- **OTHER:** Laboratory Biomarker Analysis
- **BIOLOGICAL:** Tetanus Toxoid Vaccine
- **BIOLOGICAL:** Trivalent Influenza Vaccine

## Key facts

- **NCT ID:** NCT02747407
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2020-01
- **Final completion:** 2021-09-09
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2021-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02747407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02747407, "Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02747407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*